Rare disorder due to unbalanced inter-twin blood transfusion is a serious pregnancy complication that affects identical twins who share one placenta. It happens before birth when blood flows unevenly between the twins, so one may have too little blood and fluid while the other has too much. Many people first hear about Rare disorder due to unbalanced inter-twin blood transfusion after an ultrasound shows early signs of Rare disorder due to unbalanced inter-twin blood transfusion, such as different amniotic fluid levels or poor growth in one twin. Without treatment, Rare disorder due to unbalanced inter-twin blood transfusion can raise the risk of pregnancy loss, early delivery, and heart strain in one or both twins. Treatment often includes close ultrasound monitoring, draining excess fluid, or laser treatment of placental blood vessels, and outcomes vary with how early it is found and how severe it is.
How many people live with Rare disorder due to unbalanced inter-twin blood transfusion?
Because this rare problem happens during pregnancy, doctors usually count how many pregnancies are affected each year rather than how many people are living with it long term. Using the often-cited rate of about 1 in 3,000 pregnancies (Cleveland Clinic, 2024), that suggests roughly 45,000 affected pregnancies worldwide each year (Cleveland Clinic and United Nations, 2024) and about 1,200 each year in the United States (Cleveland Clinic and CDC, 2024).
Overview
Rare disorder due to unbalanced inter-twin blood transfusionSymptoms
This rare disorder due to unbalanced inter-twin blood transfusion can make one baby look pale, small, or unusually sleepy, while the other may appear very red and puffy. Early signs can include poor feeding, breathing trouble, and low energy after birth.
Outlook and prognosis
For people with rare disorder due to unbalanced inter-twin blood transfusion, outlook can vary widely. Babies treated early often do well, while severe blood-flow imbalance may raise risks for brain, heart, or developmental problems. Follow-up helps catch any lasting effects.
Causes and risk factors
This condition is caused by uneven blood flow between identical twins who share one placenta. The main risk factor is a monochorionic twin pregnancy; it is not caused by anything a parent did, ate, or did not do.
Genetic influences
Genetics are not thought to play a major role in Rare disorder due to unbalanced inter-twin blood transfusion. It usually happens because of shared placental blood vessel connections, not an inherited gene change.
Diagnosis
Diagnosis usually relies on pregnancy ultrasound and Doppler findings, including uneven amniotic fluid, different bladder filling, and growth differences between twins. The diagnosis of rare disorder due to unbalanced inter-twin blood transfusion may need repeat scans over time.
Treatment and drugs
Treatment depends on timing and severity. During pregnancy, care may include close ultrasound checks, draining extra amniotic fluid, or laser treatment to seal shared placental blood vessels; after birth, babies may need breathing support, fluids, or blood transfusions.
Symptoms
During pregnancy, this rare disorder due to unbalanced inter-twin blood transfusion can make the abdomen feel suddenly larger, tighter, or more uncomfortable than expected. Some pregnant people feel clear changes, but many of the most important signs are first picked up on ultrasound rather than by how they feel. You might notice small changes at first, while scans may show very different fluid levels around the twins or a growing difference in their size. Because the condition can change quickly, reduced fetal movement or sudden worsening symptoms should be checked urgently.
Fluid can build up quickly around one twin, so the abdomen may seem to grow faster over days instead of weeks. Clothes may feel tighter, and the pregnancy can suddenly feel heavier.
The uterus may feel tense, stretched, or uncomfortable because of extra fluid. Some pregnant people also notice cramping, pelvic pressure, or contractions.
A very stretched uterus can press upward and make it harder to take a full breath. Some may also feel more heartburn or have trouble getting comfortable when lying down.
One or both babies may seem less active than usual. Any clear drop in usual movement patterns needs prompt medical advice.
How people usually first notice Rare disorder due to unbalanced inter-twin blood transfusion?
This condition is usually first noticed during pregnancy, often on an ultrasound when doctors see that identical twins sharing one placenta are not getting blood flow evenly, so one baby may look smaller with very little amniotic fluid while the other has too much. For many families, the first signs of this rare disorder due to unbalanced inter-twin blood transfusion are a suddenly fast-growing belly, tightness, shortness of breath, or contractions caused by extra fluid around one twin, although some pregnancies have no clear symptoms and the change is first picked up at a routine scan. Because it can develop quickly, regular prenatal follow-up is what most often catches how this condition is first noticed, giving the care team a chance to act early.
Types of Rare disorder due to unbalanced inter-twin blood transfusion
In rare disorder due to unbalanced inter-twin blood transfusion, often called twin-to-twin transfusion syndrome, doctors usually describe severity in stages rather than separate disease types. These stages reflect how blood flow is affecting each twin and how serious the changes look on ultrasound. The balance of symptoms can shift over time, so a pregnancy may move from an earlier stage to a more severe one.
Stage 1
This is the earliest stage, when one twin has too much amniotic fluid and the other has too little. The smaller donor twin's bladder is still seen on ultrasound, which suggests blood flow problems are present but not yet at the most severe level. Early symptoms of twin-to-twin transfusion syndrome may be subtle for the pregnant parent and are often first picked up during routine scans.
Stage 2
The fluid difference is still present, but the donor twin's bladder can no longer be seen on ultrasound. This usually means the donor twin is passing very little urine because blood flow to that baby is more reduced.
Stage 3
At this stage, abnormal blood flow patterns show up in the umbilical cord or other fetal blood vessels. This suggests the strain on one or both twins is increasing, and the risk of serious complications is higher.
Stage 4
One or both twins develop hydrops, which is a dangerous buildup of fluid in the body. This can affect areas such as the skin, belly, or around the lungs and heart, and it is a sign that the circulation problem has become severe.
Stage 5
This is the most severe stage and means one or both twins have died in the womb. For many living with a TTTS pregnancy, this stage reflects the far end of the same process rather than a separate type of twin-to-twin transfusion syndrome.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or home measures can meaningfully delay the start of symptoms in this rare twin pregnancy condition, because it is caused by uneven blood flow between twins who share a placenta, not by diet, exercise, sleep, or supplements. What does help is early and close prenatal care: regular ultrasound checks in twins sharing a placenta can find changes sooner, and treatment by a high-risk pregnancy team may lower the chance of serious problems, but it does not guarantee prevention. Even though you cannot control when it begins, getting expert care quickly can still make an important difference.
What genetics can tell you about symptoms
For this rare disorder, genetics usually does not tell doctors much about which symptoms will happen, how severe they will be, or when they start. The main cause is an uneven flow of blood between twins through shared blood vessels in the placenta, so symptoms are driven much more by how much blood is transferred and how early it happens in pregnancy than by inherited gene changes. In some cases, genetics may still be checked to rule out another condition that could look similar, but there is no well-established genetic pattern that predicts symptoms for this disorder itself.
Causes and risk factors
It happens only in pregnancies where twins share one placenta. Small blood vessel connections in that placenta can send too much blood to one baby and too little to the other. This rare disorder due to unbalanced inter-twin blood transfusion is known medically as twin-to-twin transfusion syndrome. Risk can vary widely from person to person, and differences in how the placenta is shared can affect how severe it becomes. It is not usually linked to genes, lifestyle, or outside exposures, and it is not caused by anything the pregnant parent did or did not do.
What are the most common causes or risk factors?
The main cause is a shared placenta in identical twins, where blood vessels connect the babies in a way that lets too much blood flow to one twin and too little to the other. The biggest risk factor is being pregnant with twins, and sometimes triplets, who share one placenta rather than each having their own. It is not usually caused by genes, family history, or anything the pregnant parent did or did not do.
Environmental and biological risk factors
In rare pregnancies where two babies share one placenta, an uneven exchange of blood can happen between them; this is known medically as twin-to-twin transfusion syndrome. Knowing the main risk factors for twin-to-twin transfusion syndrome helps guide closer ultrasound follow-up during pregnancy. Some risks are carried inside the body, others come from the world around us. For this condition, the strongest risks are biological and relate to how the shared placenta and its blood vessels formed early in pregnancy.
Twin-to-twin transfusion syndrome only occurs when babies share a single placenta, which is most common in identical twin pregnancies. If each baby has a separate placenta, this specific problem does not develop.
The condition depends on blood vessel links between the babies inside the shared placenta. When these links allow blood to move more one way than the other, the chance of imbalance rises.
Risk can be higher when one baby has access to a smaller part of the placenta. That setup can make it harder for blood flow and nutrients to stay balanced.
Some triplet or higher-order pregnancies can also be affected if two babies share one placenta. The key risk is the placental arrangement, not simply the number of babies.
Genetic risk factors
For families dealing with rare disorder due to unbalanced inter-twin blood transfusion, one of the first questions is often whether it runs in families. In most cases, it is not thought to be caused by an inherited gene change. When people ask about the genetic causes of rare disorder due to unbalanced inter-twin blood transfusion, the strongest risk is usually the pregnancy setup itself: babies sharing one placenta. The way blood vessels form inside that shared placenta matters much more than family history.
Shared placenta: Rare disorder due to unbalanced inter-twin blood transfusion develops almost only when twins share one placenta and a connected blood supply. That shared circulation creates the chance that one baby sends more blood to the other than it gets back. Risk is not destiny—it varies widely between individuals.
Vessel pattern: The exact risk depends on how the connecting placental blood vessels are arranged, including their number, size, and direction of flow. This pattern forms during early placental development and is not usually something inherited from a parent.
Identical twins: Pregnancies with identical twins are more likely to involve one shared placenta, which is the key setting for this condition. Even then, many identical twin pregnancies never develop the problem.
Family history: Doctors do not currently consider this a classic inherited disorder passed down through families. Having one affected pregnancy does not usually mean relatives are at high risk, although it can happen again if a future pregnancy also involves babies sharing one placenta.
Lifestyle risk factors
Lifestyle habits do not cause this rare disorder due to unbalanced inter-twin blood transfusion, because it arises from the shared placental circulation in a twin pregnancy. However, maternal day-to-day habits can still affect placental function, fetal growth, preterm birth risk, and how well complications are managed. In practice, how lifestyle affects rare disorder due to unbalanced inter-twin blood transfusion is mostly through supporting the healthiest possible pregnancy and helping warning signs get noticed early.
Missing appointments or delaying ultrasound follow-up can allow anemia, polycythemia, growth problems, or heart strain to worsen before they are recognized. Keeping close prenatal surveillance improves the chance that changes in either twin are detected in time for treatment or delivery planning.
Smoking or secondhand smoke can reduce oxygen delivery and impair placental blood flow. In a pregnancy already complicated by unequal blood exchange between twins, this may add stress to fetal growth and circulation.
Alcohol and non-prescribed drugs can interfere with fetal development and may worsen neurologic or growth outcomes in vulnerable twins. Avoiding these exposures is especially important when one twin may already be underperfused and the other may have blood viscosity-related complications.
Poor maternal nutrition can make it harder to support fetal growth in a pregnancy where one or both twins are already at risk of growth imbalance. A balanced intake of calories, protein, iron, and fluids helps support maternal blood volume and overall pregnancy resilience, although it does not correct the underlying transfusion problem.
Risk prevention
This condition cannot usually be fully prevented, because it happens in some identical twin pregnancies that share one placenta. In most cases, the best prevention means early recognition of a shared placenta, close prenatal follow-up, and timely treatment if warning signs appear. Prevention is about lowering risk, not eliminating it completely.
The most important step is early pregnancy ultrasound to confirm whether the twins share a placenta, because that is where this condition can develop. Once a shared placenta is identified, care can be planned around the higher risk.
Frequent scans during pregnancy can catch fluid changes, growth differences, or blood-flow problems before severe illness develops. This is one of the best ways to lower the chance of late diagnosis and spot early symptoms of twin-to-twin transfusion problems.
Many people with a monochorionic twin pregnancy benefit from seeing a maternal-fetal medicine specialist. Specialized care makes it easier to decide when monitoring should increase and when treatment may be needed.
Missing prenatal visits can delay finding changes that may happen quickly in twin pregnancies sharing one placenta. Prevention works best when combined with regular check-ups.
Can you prevent Rare disorder due to unbalanced inter-twin blood transfusion?
No, this condition usually cannot be fully prevented, because it happens when twins share one placenta and blood flows unevenly between them, not because of anything a parent did or did not do. In pregnancies with twins sharing a placenta, early prenatal care and regular ultrasound checks can help find it sooner and lower the chance of serious problems, but they do not stop it from happening.
Transmission
Rare disorder due to unbalanced inter-twin blood transfusion is not infectious at all, so it cannot be caught from another person or spread through touch, breathing, sex, food, or blood contact. It develops only during pregnancy, usually when identical twins share one placenta and the blood vessels in that placenta let too much blood flow from one twin to the other.
If you are wondering how Rare disorder due to unbalanced inter-twin blood transfusion is inherited, it usually is not inherited from a parent and is not known to spread through families in a typical way. For many families, this means the condition starts because of how the shared placenta formed, not because anyone did anything wrong.
When to test your genes
Genetic testing is not usually helpful for this condition because it is caused by abnormal blood flow between twins during pregnancy, not by an inherited gene change. Testing may be considered only if doctors suspect a separate genetic condition or unexpected birth differences that could affect care.
Diagnosis
Rare disorder due to unbalanced inter-twin blood transfusion is usually picked up during pregnancy, often after scan findings suggest one baby is receiving too much blood flow while the other is receiving too little. This can happen in identical twins who share a placenta, and the diagnosis often depends on ultrasound patterns rather than symptoms you can feel. Doctors usually begin with routine prenatal imaging, then use more detailed tests to confirm the diagnosis of Rare disorder due to unbalanced inter-twin blood transfusion.
Ultrasound is the main test used to look for signs that the twins are affected differently. The sonographer checks each baby's size, movement, amniotic fluid, and how full the bladder looks, because these findings can point to an imbalance in blood flow.
A major clue is a clear difference in the amount of amniotic fluid around each twin. One baby may appear crowded with very little fluid, while the other may have too much, which is a classic pattern in how Rare disorder due to unbalanced inter-twin blood transfusion is diagnosed.
Repeated scans help show whether one twin is growing more slowly or showing signs of stress. Tracking changes over time is important, because some pregnancies look mild at first and become more concerning later.
Doppler ultrasound measures blood flow in key fetal blood vessels and the umbilical cord. These imaging findings can show how much strain each baby is under and help doctors judge how urgent treatment may be.
How is Rare disorder due to unbalanced inter-twin blood transfusion diagnosed?
This condition is usually diagnosed during pregnancy with ultrasound scans in twins who share one placenta. Doctors look for an uneven pattern between the babies, such as one baby having too little fluid around them and an almost empty bladder, while the other has too much fluid, a fuller bladder, or signs that the heart is under strain; they may also use a special ultrasound to check blood flow. After birth, the diagnosis may be supported by clear differences in blood count, size, or fluid balance between the twins, but it is most often picked up before delivery.
Stages of Rare disorder due to unbalanced inter-twin blood transfusion
Doctors usually divide this rare disorder due to unbalanced inter-twin blood transfusion into five stages, based on ultrasound findings during pregnancy. In day-to-day terms, the stages show how much strain the blood-flow imbalance is placing on the babies, rather than how a parent may feel physically. Different tests may be suggested to help confirm the stages of twin-to-twin transfusion syndrome, including ultrasound checks of amniotic fluid, the bladder, blood flow, and signs of fluid buildup.
Stage 1
One baby has too much amniotic fluid, while the other has too little. Blood flow studies still look normal, and the donor baby's bladder can still be seen on ultrasound.
Stage 2
The donor baby's bladder is no longer visible during the scan. The fluid difference between the twins is still present, showing the imbalance has become more severe.
Stage 3
Blood flow tests now show concerning changes in one or both babies. This means the circulation problem is starting to affect how well the heart and blood vessels are coping.
Stage 4
One or both babies develop a buildup of fluid in the body, a serious sign sometimes called hydrops. This suggests the strain on the heart has become severe.
Stage 5
One or both babies die in the womb. This is the most advanced stage and reflects severe complications from twin-to-twin transfusion syndrome.
Outlook and prognosis
The outlook depends greatly on how early the imbalance is recognized, how severe it is, and whether treatment can be provided before major complications develop. In severe cases, especially when it occurs in monochorionic twin pregnancies and is not treated promptly, there is a substantial risk of fetal loss, preterm birth, neurologic injury, heart strain, and other long-term complications in one or both twins. With modern fetal monitoring and interventions such as laser therapy or timely delivery when indicated, survival has improved markedly, and many affected infants do well, although careful follow-up is often needed after birth. Mortality is highest in untreated or advanced cases, and the death of one or both twins can occur, particularly when the blood flow imbalance causes profound anemia, polycythemia, or circulatory overload. Among survivors, long-term prognosis ranges from normal development to persistent problems related to prematurity or organ injury, so outcomes vary widely from case to case.
Long-term effects
For babies who survive twin-to-twin transfusion syndrome, the long-term outlook can range from no lasting problems to ongoing medical and developmental needs. Long-term effects vary widely, and much depends on how severe the condition was before birth, how early it was treated, and whether the brain or other organs were affected. Some children grow and learn much like their peers, while others need follow-up for movement, learning, hearing, vision, or heart-related concerns.
Some children have delays in speech, learning, attention, or motor skills as they grow. Early signs may be subtle at first, such as taking longer to sit, walk, or keep up at school.
Reduced blood flow or other complications before birth can sometimes lead to lasting brain injury. In some survivors, this can cause cerebral palsy, seizures, or other neurologic problems later on.
Many living with twin-to-twin transfusion syndrome grow well, but some may remain smaller than expected in infancy or childhood. Growth can differ between the twins, especially if one had more severe strain before birth.
The twin who received extra blood flow may have had more stress on the heart before birth, and some heart changes can persist. Doctors may track heart size, function, or blood pressure over years to see how recovery is going.
How is it to live with Rare disorder due to unbalanced inter-twin blood transfusion?
Living with a rare disorder caused by unbalanced blood flow between twins often begins before birth, when what should be an ordinary twin pregnancy suddenly turns into one that needs close, specialized care. During pregnancy, families may face frequent ultrasounds, possible fetal procedures, more medical appointments, and the stress of not knowing how each baby will do; after birth, some babies recover well, while others may need time in the neonatal intensive care unit and ongoing follow-up for growth, heart function, or development. For parents, siblings, and other loved ones, this can reshape daily life around hospital visits, caregiving, and worry, but many families find that clear medical support, practical help, and early follow-up make the road ahead more manageable.
Treatment and drugs
Treatment for a rare disorder due to unbalanced inter-twin blood transfusion depends a lot on when it is found, because care during pregnancy is different from care after birth. During pregnancy, doctors usually monitor both twins very closely with frequent ultrasound scans, and some pregnancies are treated with a procedure that seals the blood vessel connections in the placenta so blood flow is more balanced; in some cases, removing extra amniotic fluid or planning early delivery may also help. After birth, treatment focuses on the problems each baby has, which can include help with breathing, fluids, blood transfusion for anemia, or treatment to lower a very high red blood cell count. Treatment plans often combine several approaches. Because the effects can vary from mild to serious, babies are often cared for by a team that may include newborn specialists, heart specialists, and neurologists.
Can you cure Rare disorder due to unbalanced inter-twin blood transfusion?
No, there is not a simple cure for this rare condition, but doctors can often treat the uneven blood flow between twins and lower the risk of serious problems. During pregnancy, this may mean very close checkups and, in some cases, a procedure to seal the shared blood vessels in the placenta that are causing the imbalance. After birth, babies may still need treatment for problems such as low blood count, breathing trouble, or heart strain.
Non-drug treatment
During a twin pregnancy, this rare disorder due to unbalanced inter-twin blood transfusion can change quickly, so care usually centers on close monitoring and fetal procedures rather than medicines. It is often called twin-to-twin transfusion syndrome, and treatment depends on how far along the pregnancy is and how severely each twin is affected. Managing this condition often means seeing a maternal-fetal medicine team with experience in high-risk twin pregnancies. The main goals are to improve blood flow balance, reduce strain on the twins' hearts, and safely prolong the pregnancy when possible.
Frequent ultrasound scans are a core part of care, often checking growth, amniotic fluid, bladder filling, and blood flow in each twin. These visits help the team spot early symptoms of twin-to-twin transfusion syndrome getting worse and decide when a procedure is needed.
Fetoscopic laser treatment is the main procedure for many severe cases before birth. A specialist uses a tiny camera and laser to seal the shared placental blood vessels that are causing the uneven blood flow.
Amnioreduction removes extra amniotic fluid from around the receiving twin with a needle guided by ultrasound. This can lower pressure in the uterus and may ease short-term risk, but it does not fix the underlying vessel problem.
Septostomy is a less commonly used procedure that creates a small opening in the membrane between the twins. It may help balance fluid in selected cases, but it is generally used less often than laser treatment because risks and benefits can vary.
Your genes may have an impact on how drugs work for you
For this condition, genes usually do not play a known or important role in how treatment works, because care is mainly based on the babies’ blood flow problems and related complications rather than on inherited differences in drug handling. Many living with problems linked to this condition may receive supportive care, such as treatment for anemia, heart strain, or fluid balance, and these medicines are usually chosen by watching how the body responds in real time. In short, genetic testing to guide medicine choice is not a routine or well-established part of care for this condition.
Pharmacological treatments
For this rare disorder caused by unbalanced blood flow between twins during pregnancy, there is no medicine that fixes the blood-vessel problem itself. Treatment is usually centered on close monitoring and fetal procedures, while drugs are used to support the pregnancy, prepare for preterm birth, or help with symptoms and procedure-related needs. Not everyone responds to the same medication in the same way. In practice, the treatment for twin-to-twin transfusion syndrome during pregnancy often includes medicines only as part of a broader care plan.
There is no medication that can directly stop the abnormal blood transfer between the twins. The main treatment is usually a procedure such as laser treatment of the shared placental vessels, with medicines used as support rather than as a cure.
Betamethasone is a steroid often given if early delivery is possible, because it helps the babies' lungs mature faster. This can lower the risk of breathing problems if birth happens too soon.
Magnesium sulfate may be given when very preterm birth seems likely, especially before about 32 weeks. It is mainly used to help protect the babies' developing brains around the time of delivery.
Drugs that relax the uterus, such as nifedipine, indomethacin, or atosiban where available, may be used to reduce contractions around a fetal procedure or threatened preterm labor. Sometimes medicines are taken short-term, while others are used long-term, but in this setting they are usually short-term support.
Genetic influences
When one twin is getting too little blood and the other too much, many families wonder whether this rare disorder due to unbalanced inter-twin blood transfusion is genetic. It’s natural to ask whether family history plays a role. In most cases, the answer is no: this problem usually happens because identical twins share one placenta and develop blood vessel connections that let blood flow unevenly between them, not because a parent passed down a disease-causing gene. Researchers are still studying whether genes might slightly affect placental development or the chance of having identical twins, but there is no well-established inherited cause for most cases. For many, this means the condition is usually thought of as a complication of how the placenta formed during that pregnancy rather than something that strongly runs in families.
Is Rare disorder due to unbalanced inter-twin blood transfusion genetic?
Genetics are not thought to play a major role in Rare disorder due to unbalanced inter-twin blood transfusion. It usually happens because of shared placental blood vessel connections, not an inherited gene change.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal part of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. In many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When doctors plan treatment for a rare disorder due to unbalanced inter-twin blood transfusion, the key decisions usually depend on how each baby is doing on ultrasound and how far along the pregnancy is, rather than on inherited gene differences. This condition, known medically as twin-to-twin transfusion syndrome, is usually caused by shared placental blood vessels instead of a gene change that helps doctors choose one drug over another. Not every difference in response is genetic, but there is no established pharmacogenetic test that guides the medicines used during treatment for twin-to-twin transfusion syndrome. Care often focuses on procedures such as laser treatment of the shared vessels, while medicines like anesthesia, pain relief, or steroids to support fetal lung maturity before an early birth are chosen based on the situation. For many, close monitoring and timing of treatment matter far more than genetics.
Interactions with other conditions
For families dealing with a rare disorder due to unbalanced inter-twin blood transfusion, day-to-day concerns often center on how it can add to other newborn health problems rather than staying as a single issue. Babies affected by this condition are often born early, and prematurity can combine with it to raise the risk of breathing trouble, feeding difficulties, infection, and bleeding in the brain. Doctors call it a comorbidity when two conditions occur together, and in this setting heart strain, severe anemia in one twin, or very thick blood in the other can make recovery more complicated. Some infants also have poor growth before birth, and that can interact with low blood sugar, jaundice, or temperature instability after delivery. When blood-flow imbalance has been severe, there may also be a higher chance of long-term problems such as developmental delay or cerebral palsy, especially if prematurity is also present. Because the effects can differ between the donor and recipient twin, careful follow-up helps doctors watch for the early symptoms of complications and tailor care to each baby’s needs.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Rare disorder due to unbalanced inter-twin blood transfusion?
Other problems in a twin pregnancy can look similar, especially when one baby is much smaller than the other or there is too much fluid around one baby. The most important look-alikes are selective growth restriction, where one twin does not grow well, and twin anemia-polycythemia sequence, where one twin has too few red blood cells and the other has blood that is too thick. In the pregnant person, too much amniotic fluid from other causes or preeclampsia can also lead to a fast-growing belly, swelling, or discomfort that may seem similar at first.
History
For families expecting twins who share a placenta, one of the biggest worries can be hearing that the babies are no longer growing in the same way or that fluid around one twin is rising while the other seems cramped. What is now called twin-to-twin transfusion syndrome, a rare disorder due to unbalanced inter-twin blood transfusion, was not always well understood. Early doctors and midwives could see that some shared-placenta twin pregnancies ended very differently for each baby, but they did not yet know why.
As medical science evolved, doctors began linking these uneven outcomes to blood vessel connections inside the shared placenta. By the 19th and early 20th centuries, reports described one twin looking pale and smaller and the other appearing more full-blooded or swollen, clues that blood flow between the twins had become unbalanced before birth. These observations helped move the condition from a mystery to a recognizable pregnancy complication, even though diagnosis during pregnancy was still very limited.
In recent decades, awareness has grown as ultrasound made it possible to follow shared-placenta twin pregnancies much more closely. Doctors could now spot early signs of twin-to-twin transfusion syndrome, including differences in amniotic fluid, bladder size, and growth, often before severe problems developed. This changed care in a practical way: instead of finding the problem only after delivery, care teams could monitor the pregnancy week by week and make treatment decisions sooner.
Treatment has also changed significantly over time. Earlier care was mostly supportive and often focused on managing complications as they appeared. More recently, specialized fetal procedures that treat the abnormal blood vessel connections in the placenta have improved outcomes for many families. Not every pregnancy follows the same course, and twin-to-twin transfusion syndrome can still be very serious, but the history of this condition is also a story of better recognition, earlier diagnosis, and more effective care for both babies and the pregnant parent.